Futura Medical plc (FRA:GYX)
Germany
· Delayed Price · Currency is EUR 0.0075
0.00 (0.00%)
At close: Dec 4, 2025
Futura Medical Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 7.93 | 13.93 | 3.1 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | -5.62% | 349.09% | - | - | - | - | Upgrade
|
| Cost of Revenue | 2.81 | 4.24 | 1.33 | - | - | - | Upgrade
|
| Gross Profit | 5.11 | 9.69 | 1.77 | - | - | - | Upgrade
|
| Selling, General & Admin | 9.64 | 6.83 | 6.69 | 2.74 | 2.09 | 1 | Upgrade
|
| Research & Development | 1.89 | 1.74 | 2.05 | 4.13 | 3.77 | 1.93 | Upgrade
|
| Other Operating Expenses | -0.13 | -0.13 | - | - | - | - | Upgrade
|
| Operating Expenses | 11.41 | 8.45 | 8.74 | 6.87 | 5.87 | 2.93 | Upgrade
|
| Operating Income | -6.3 | 1.24 | -6.96 | -6.87 | -5.87 | -2.93 | Upgrade
|
| Interest & Investment Income | 0.04 | 0.05 | 0.07 | - | - | 0 | Upgrade
|
| Pretax Income | -6.26 | 1.29 | -6.89 | -6.87 | -5.87 | -2.93 | Upgrade
|
| Income Tax Expense | 0.03 | -0 | -0.38 | -1.02 | -0.91 | -0.52 | Upgrade
|
| Net Income | -6.29 | 1.29 | -6.51 | -5.85 | -4.96 | -2.41 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Income to Common | -6.29 | 1.29 | -6.51 | -5.85 | -4.96 | -2.41 | Upgrade
|
| Shares Outstanding (Basic) | 303 | 302 | 295 | 287 | 271 | 244 | Upgrade
|
| Shares Outstanding (Diluted) | 303 | 311 | 295 | 287 | 271 | 244 | Upgrade
|
| Shares Change (YoY) | 0.70% | 5.38% | 2.59% | 6.06% | 11.21% | 19.09% | Upgrade
|
| EPS (Basic) | -0.02 | 0.00 | -0.02 | -0.02 | -0.02 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.02 | 0.00 | -0.02 | -0.02 | -0.02 | -0.01 | Upgrade
|
| Free Cash Flow | -0.44 | -1.34 | -0.94 | -6.52 | -4.29 | -4.55 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Gross Margin | 64.49% | 69.58% | 57.22% | - | - | - | Upgrade
|
| Operating Margin | -79.48% | 8.93% | -224.57% | - | - | - | Upgrade
|
| Profit Margin | -79.41% | 9.29% | -210.03% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -5.56% | -9.59% | -30.17% | - | - | - | Upgrade
|
| EBITDA | -6.18 | 1.37 | -6.83 | -6.85 | -5.85 | -2.9 | Upgrade
|
| EBITDA Margin | -77.91% | 9.81% | -220.37% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.12 | 0.12 | 0.13 | 0.02 | 0.02 | 0.03 | Upgrade
|
| EBIT | -6.3 | 1.24 | -6.96 | -6.87 | -5.87 | -2.93 | Upgrade
|
| EBIT Margin | -79.48% | 8.93% | -224.57% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.